Annual report pursuant to Section 13 and 15(d)

NET LOSS PER SHARE - Summary Of Diluted Shares Outstanding (Detail)

v3.23.1
NET LOSS PER SHARE - Summary Of Diluted Shares Outstanding (Detail) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Restricted stock grants with only service conditions    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 3,552,416 0
Common stock issued under the Backstop Agreement    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 9,600,031 9,600,031
Private Placement Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 272,779 272,779
Series C Convertible Preferred Stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 0 2,566,186
Stock Options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 0 432,500